Is the risk of morbidity and rare mortality worth the cure?
Giulio J. D’Angio(University of Pennsylvania), Melvin Tefft(Cleveland Clinic), H. William Clatworthy, William A. Newton(Children's Oncology Group), Audrey E. Evans(Purdue University West Lafayette)
Cited by 16
Related Papers
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.
|Journal of Clinical Oncology|1988|608
The treatment of medulloblastoma
|Journal of neurosurgery|1990|583